• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:

Cell & Gene Therapy

Explore the latest news and insight around cell and gene therapy, including new technology and information on treatments in this growing field. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Brought to you by:
0
Space shuttle takes off on background of blue sky
Biotech

Rocket aborts mission to get rare disease gene therapy approved

Having already altered the journey of its rare disease gene therapy toward FDA approval, Rocket Pharmaceuticals has now aborted the mission entirely.
James Waldron Oct 3, 2025 9:30am
Red boxing gloves

Takeda lays off 137 US staff as part of cell therapy retreat

Oct 1, 2025 3:13pm
cardiovascular disease

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Sep 30, 2025 1:55pm
Close-up of human eye

Opus sets sights on FDA talks after posting gene therapy data

Sep 30, 2025 9:15am
denovirus transmission replication treatments 3D scientific illustration

Biogen discontinues all AAV gene therapy work

Sep 26, 2025 11:04am
business targets illustration

uniQure plans FDA push after Huntington's gene therapy trial win

Sep 24, 2025 9:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings